Enzyme replacement in Fabry disease: treatment of cultured skin fibroblasts with a purified alpha-galactosidase from ficin.
D002250:Carbon Radioisotopes; D002478:Cells, Cultured; D002518:Ceramides / Q000378:metabolism; D004355:Drug Stability; D000795:Fabry Disease / Q000188:drug therapy*; D005347:Fibroblasts / Q000032:analysis / Q000378:metabolism; D005696:Galactosidases / Q000008:administration & dosage / Q000302:isolation & purification / Q000378:metabolism / Q000627:therapeutic use*; D005947:Glucose / Q000378:metabolism; D006017:Glycolipids / Q000032:analysis; D006801:Humans; D008055:Lipids / Q000032:analysis; D010743:Phospholipids / Q000032:analysis; D012867:Skin / Q000032:analysis / Q000378:metabolism; D013107:Sphingolipids / Q000032:analysis
D002250:Carbon Radioisotopes; D002518:Ceramides; D006017:Glycolipids; D008055:Lipids; D010743:Phospholipids; D013107:Sphingolipids; D005696:Galactosidases; D005947:Glucose